10x Genomics Inc (TXG) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TXG Annual Balance Sheets →
The data below summarizes 10x Genomics Inc's balance sheet position from Sep 30 2025 to Sep 30 2026, enabling a period-by-period comparison of financial strength.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TXG/balance-sheets
https://api.csimarket.com/api/v1/companies/TXG/fundamentals
https://api.csimarket.com/api/v1/companies/TXG/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent526.19
Available-for-sale Securities, Debt Securities, Current MA49.54
Cash & Short-term Investments575.00
Accounts receivable55.70
Other Receivables, Net, Current3.06
Inventories64.63
Prepaid Expense And Other Assets Current19.57
Total Current Assets718.63
Equipment/Property/Plant Net385.00
Goodwill net6.92
Intangible Assets58.66
Other Assets, Noncurrent0.00
Restricted Cash Noncurrent-
Total Assets1,063.13
Liabilities
Accounts Payable, Current AC21.59
Employee-related Liabilities, Current AC39.66
Estimated Litigation Liability, Current0.00
Other Liabilities, Current72.14
Taxes Payable6.98
Total Current Liabilities140.37
Total Long-term Debt0.00
Estimated Litigation Liability, Noncurrent LI0.00
Other liabilities, Noncurrent84.72
Contract With Customer Liability Current24.34
Contract With Customer Liability Noncurrent10.14
Operating Lease Liability Noncurrent70.06
Total Liabilities225.09
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2,399.25
Retained Earnings / Accumulated Deficit-1,561.42
Accumulated Other Comprehensive Income0.20
Other Equity0.20
Common Stockholder's Equity838.04
Total Stockholder's Equity838.04
Liabilities & Stockholder's Equity1,063.13
4 historic quarters locked

Sign in to unlock the full 10x Genomics Inc balance sheet history.

About 10X Genomics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 5, 2026
  • Source: txg-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-071199

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI